One hundred and nineteen patients of epididymal stasis post-vasal sterilization were treated with ultrasonic therapy (therapeutic power was 0.5-0.8w/cm2). The clinical efficacy follow-up study was carried out at 1, 3,...One hundred and nineteen patients of epididymal stasis post-vasal sterilization were treated with ultrasonic therapy (therapeutic power was 0.5-0.8w/cm2). The clinical efficacy follow-up study was carried out at 1, 3, 6, and 12 month after treatment. It was found that epididymal stasis occurred more common on the left side (61.34%).The symptoms of patients were mostly of mild type (88/119, 73.95%). The anteroposterior diameter of stasis epididymis was first monitored with ultrasonography.Serum level of FSH, ICSH and T were measured by RIA, serum antisperm antibodies were detected by TAT in 97, 53 and 36/119 cases, separately. This prospective investigation displayed that the anteroposterior diameter of epididymis reduced gradually with symptomatic improvement. FSH, ICSH and T levels fluctuated within normal lim-its and the positive incidence or titres of antisperm antibodies did not change significantly when compared with pre-therapy. The clinical efficacy rate was 82.74% and a therapeutic course of 7 days could maintain an efficacy for 1 year. This study suggested that ultrasonic therapy would not disturb human endocrinologic and immunologic function. It provides a new approach for clinical diagnosis and treatment to epididymal stasis.展开更多
文摘One hundred and nineteen patients of epididymal stasis post-vasal sterilization were treated with ultrasonic therapy (therapeutic power was 0.5-0.8w/cm2). The clinical efficacy follow-up study was carried out at 1, 3, 6, and 12 month after treatment. It was found that epididymal stasis occurred more common on the left side (61.34%).The symptoms of patients were mostly of mild type (88/119, 73.95%). The anteroposterior diameter of stasis epididymis was first monitored with ultrasonography.Serum level of FSH, ICSH and T were measured by RIA, serum antisperm antibodies were detected by TAT in 97, 53 and 36/119 cases, separately. This prospective investigation displayed that the anteroposterior diameter of epididymis reduced gradually with symptomatic improvement. FSH, ICSH and T levels fluctuated within normal lim-its and the positive incidence or titres of antisperm antibodies did not change significantly when compared with pre-therapy. The clinical efficacy rate was 82.74% and a therapeutic course of 7 days could maintain an efficacy for 1 year. This study suggested that ultrasonic therapy would not disturb human endocrinologic and immunologic function. It provides a new approach for clinical diagnosis and treatment to epididymal stasis.
